Development of a mucosal complex vaccine against oral Salmonella infection in mice

Microbiology and Immunology

Volumn 46, Issue 12, 2002, Pages 891-905

  Harada, Hiroko ^a   Nishikawa, Fumiko ^a   Higashi, Nobutaka ^a   Kita, Eiji ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Delayed hypersensitivity; Mucosal adjuvant; Mucosal IgA; Murine salmonellosis; Th1 response

Indexed keywords

CHOLERA TOXIN; FLAGELLIN; GAMMA INTERFERON; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 10; INTERLEUKIN 2; SALMONELLOSIS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; FEMALE; IMMUNOGENICITY; LAMINA PROPRIA; MOUSE; NONHUMAN; PEYER PATCH; POLYSOME; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; T LYMPHOCYTE; TH1 CELL;

ANIMALIA; MURINAE; NEGIBACTERIA; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM;

EID: 0036912991     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2002.tb02778.x     Document Type: Article

References (46)

1. Amons, R., and Mller, W. 1972. On the mode of reaction of formaldehyde with ribosomes. Biochem. Biophys. Acta 272: 95-107.
2. Beagley, K.W., Eldridge, J.H., Lee, F., Kiyono, H., Everson, M.P., Koopman, W.J., Hirano, T., Kishimoto, T., and McGhee, J.R. 1989. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J. Exp. Med. 169: 2133-2148.
3. Bland, P.W., Richens, E.R., Britton, D.C., and Lloyd, J.V. 1979. Isolation and purification of human large bowel mucosal lymphoid cells: Effect of separation technique on functional characteristics. Gut 20: 1037-1046.
4. Boyaka, P.M., Marinaro, M., Jackson, R.J., Menson, S., Kiyono, H., Jirillo, E., and McGhee, J.R. 1999. IL-12 is an effective adjuvant for the induction of mucosal immunity. J. Immunol. 162: 122-128.
5. Briere, F., Bridon, J.-M., Chevet, D., Souillet, G., Bienvenu, F., Guret, C., Martinez-Valdez, H., and Banchereau, J. 1994. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secret IgA. J. Clin. Invest. 94: 97-104.
6. Butler, R.C., Friedman, H., Specter, S.C., and Eisenstein, T.K. 1981. Induction of immunoenhancing factors for murine splenocyte cultures by Salmonella typhimurium ribosomes and nucleic acid extracts. Infect. Immun. 32: 1123-1127.
7. Carsiotis, M., Weinstein, D.L., Karch, H., Holder, I.A., and O'Brien, A.D. 1984. Flagella of Salmonella typhimurium are a virulence factor in infected C57BL/6 mice. Infect. Immun. 46: 814-818.
8. Chong, C., Friberg, M., and Clements, J.D. 1998. LT (R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp. Vaccine 16: 732-740.
9. Ciacci-Woolwine, F., Blomfield, I.C., Richardson, S.H., and Mizel, S.B. 1998. Salmonella flagellin induces tumor necrosis factor α in a human promonocytic cell line. Infect. Immun. 66: 1127-1134.
10. Coffman, R.L., Shrader, B., Carty, J., Mossman, T.R., and Bond, M.W. 1987. A mouse T cell product that preferentially enhances IgA production. I. Biological characterization. J. Immunol. 139: 3685-3690.
11. Czerkinsky, C., and Holmgren, J. 1995. The mucosal immune system and prospects for anti-infectious and anti-inflammatory vaccines. Immunologist 3: 97-103.
12. Czerkinsky, C.C., Nilsson, L.A., Nygren, H., Ouchterlony, O., and Tarkowski, A. 1983. A solid phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol, Methods 65: 109-121.
13. Defrance, T., Vanbervliet, B., Briere, F., Durand, I., Rousett, F., and Banchereau, J. 1992. Interleukin-10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A.J. Exp. Med. 175: 671-682.
14. Dinarello, C.A. 2000. Interleukin-18, a proinflammatory cytokine. Eur. Cytokine Netw. 11: 483-486.
15. Eaves-Pyles, T., Murthy, K., Liaudet, L., Virg, L., Ross, G., Soriano, F.G., Szab, C., and Salzman, A.L. 2001. Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: IκBα degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction. J. Immunol. 166: 1248-1260.
16. George, A. 1996. Generation of gamma interferon responses in murine Peyer's patches following oral immunization. Infect. Immun. 64: 4606-4611.
17. Gewirtz, A.T., Simon, P.O., Jr., Schmitt, C.K., Taylor, L.J., Hagedorn, C.H., O'Brien, A.D., Neish, A.S., and Madara, J.L. 2001. Salmonella typhimurium translocates flagellin across intestinal epithelia, inducing a proinflammatory response. J. Clin. Invest. 1007: 99-109.
18. Hassan, J.O., and Curtiss, III, R. 1994. Development and evaluation of an experimental vaccination program using a live avirulent Salmonella typhimurium strain to protect immunized chickens against challenge with homologous and heterologous Salmonella serotypes. Infect. Immun. 62: 5519-5527.
19. Hayashi, F., Smith, K.D., Ozinsky, A., Hawn, T.R., Yi, E.C., Goodlett, D.R., Eng, J.K., Akira, S., Underhill, D.M., and Aderem, A. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103.
20. Horner, A.A., and Raz, E. 2000. Immunostimulatory sequence oligodeoxynucleotide: A novel mucosal adjuvant. Clin. Immunol. 95: S19-S29.
21. Ibrahim, G.I., Fleet, G.H., Lyons, M.J., and Walker, R.A. 1985. Method for the isolation of highly purified Salmonella flagellins. J. Clin. Microbiol. 22: 1040-1044.
22. Kanangat, S., Solomon, A., and Rouse, B.T. 1992. Use of quantitative polymerase chain reaction to quantitate cytokine messenger RNA molecules. Mol. Immunol. 29: 1229-1236.
23. Kita, E., Emoto, M., Nishikawa, F., Yoshikai, Y., and Kashiba, S. 1995. Conversion of Salmonella typhimurium to L-forms contributes to the maintenance of acquired immunity against murine typhoid. Immunology 86: 206-211.
24. Kita, E., Emoto, M., Yasui, K., Yasui, K., Katsui, N., Nishi, K., and Kashiba, S. 1986. Cellular aspects of the longer-lasting immunity against mouse typhoid infection afforded by the live-cell and ribosomal vaccines. Immunology 57: 431-435.
25. Kita, E., Matsuda, Y., Matsuda, K., and Kashiba, S. 1984. Separate transfer of mouse protection and delayed-type hypersensitivity with Salmonella typhimurium transfer factor. Cell. Immunol. 87: 528-537.
26. Kita, E., Matsuura, H., Masuda, S., Tomihata, S., and Kashiba, S. 1983. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. I. Preparation of the protective dialyzable factor from the ribosomal fraction by the freeze-thaw procedure. Microbiol. Immunol. 27: 7-24.
27. Kita, E., Oku, D., Nishikawa, F., Emoto, M., Yasui, K., and Kashiba, S. 1991. Requirement of the conformational stability of a Salmonella ribosomal vaccine for its mouse protection. FEMS Microbiol. Immunol. 76: 229-240.
28. Kita, E., Yasui, K., Yasui, K., Matsuda, Y., Matsuda, K., and Kashiba, S. 1984. Immunogenic dialyzable factor derived from a ribosomal fraction of Salmonella typhimurium. III. Analysis of resistance induced by dialyzable factors. Microbiol. Immunol. 28: 807-820.
29. Klimpel, G.R., Asuncion, M., Haithcoat, J., and Niesel, D.W. 1995. Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infect. Immun. 63: 1134-1137.
30. Kurioka, T., Yunou, Y., and Kita, E. 1998. Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157: H7 by protein calorie malnutrition in mice. Infect. Immun. 66: 1726-1734.
31. Levine, M.M., Ferriccio, C., Black, R.E., and Germanier, R. 1987. Large-scale field trial of Ty21a live oral typhoid vaccine in enteric coated capsule formulation. Lancet i: 1049-1052.
32. Levine, M.M., Hone, D., Tacket, C., Ferreccio, C., and Cryz, S. 1990. Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines. Res. Microbiol. 141: 807-816.
33. Marinaro, M., Staats, H.F., Hiroi, T., Jackson, R.J., Coste, M., Boyaka, P.N., Okahashi, N., Yamamoto, M., Kiyono, H., Bluethmann, H., Fujihashi, K., and McGhee, J.R. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155: 4621-4629.
34. +T cell responses during natural infection with Salmonella typhimurium. J. Immunol. 164: 986-993.
35. Nishikawa, F., Yoshikawa, S., Harada, H., Kita, M., and Kita, E. 1998. The full expression of the Ity phenotype in Ity mice requires C3 activation by Salmonella lipopolysaccharide. Immunology 95: 640-647.
36. Ron, E.Z., Kohler, R.E., and Davis., B.D. 1966. Polysome extracted from Escherichia coli by freeze-thaw-lysozyme lysis. Science 153: 1119-1120.
37. Sonouchi, E.K., Hamilton, T.A., Tannenbaum, C.S., Tubbs, R.R., Bukowski, R., and Finke, J.H. 1994. Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with interferon-α and interleukin 2. Am. J. Pathol. 144: 747-755.
38. Staats, H.F., and McGhee, J.R. 1996. Application of basic principles of mucosal immunity to vaccine development, p. 15-40. In Kiyono, H., Ogra, P.L., and McGhee, J.R. (eds), Mucosal Vaccines, Academic Press, San Diego.
39. Svetic, A., Finkelman, F.D., Jian, Y.C., Dieffenbach, C.W., Scott, D.E., McCarthy, K.F., Steinberg, A.D., and Gause, W.G. 1991. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147: 2391-2397.
40. Sztein, M.B., Wasserman, S.S., Tacket, C.O., Edelman, R., Hone, D., Lindberg, A.A., and Levine., M.M. 1994. Cytokine production patterns and lymphoproliferative response in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J. Infect. Dis. 170: 1508-1517.
41. Tacket, C.O., Sztein, M.B., Losonsky, G.A., Wasserm, S.S., Nataro, J.P., Edelman, R., Pickard, D., Dougan, G., Chatfield, S.N., and Levine, M.M. 1997. Safety of live oral Salmonella typhi vaccine strains with deletion in htrA and aroC aroD and immune response in humans. Infect. Immun. 65: 452-456.
42. Ushino, S., Namba, M., Okura, T., Hattori, K., Nukada, Y., Akita, K., Tanabe, E., Konishi, K., Micallef, M., Fujii, M., Torigoe, K., Tanimoto, T., Fukuda, S., Ikeda, M., Okamura, H., and Kurimoto., M. 1996. Cloning of the cDNA for human IFN- γ-inducing factor, expression in Escherichia coli, and studies on the biological activities of the protein. J. Immunol. 156: 4274-4279.
43. VanCott, J.L., Staats, H.F., Pascual, D.W., Roberts, M., Chatfield, S.N., Yamamoto, M., Carter, P.B., Kiyono, H., and McGhee, J.R. 1996. Regulation of mucosal and systemic antibody responses by helper T cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immunol. 156: 1504-1514.
44. Venneman, M.R., and Bigley, N.J. 1969. Isolation and partial characterization of an immunogenic moiety obtained from Salmonella typhimurium. J. Bacteriol. 100: 140-148.
45. Williams, N.A., Hirst, T.R., and Nashar, T.O. 1999. Immune modulation by the cholera-like enterotoxins: From adjuvant to therapeutic. Immunol. Today 20: 95-101.
46. Xu-Amano, J., Kiyono, H., Jackson, R.J., Staats, H.F., Fujihashi, K., Burrows, P.D., Elson, C.O., Pillai, S., and McGhee, J.R. 1993. Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178: 1309-1320.